{"name":"Delcath Systems Inc.","slug":"delcath-systems-inc","ticker":"","exchange":"","domain":"delcathsystems.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cisplatin and Gemcitabine","genericName":"Cisplatin and Gemcitabine","slug":"cisplatin-and-gemcitabine","indication":"Non-small cell lung cancer","status":"phase_2"},{"name":"regional chemotherapy","genericName":"regional chemotherapy","slug":"regional-chemotherapy","indication":"Liver cancer, including hepatocellular carcinoma","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Trifluridine-tipiracil plus Bevacizumab Alone","genericName":"Trifluridine-tipiracil plus Bevacizumab Alone","slug":"trifluridine-tipiracil-plus-bevacizumab-alone","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Cisplatin and Gemcitabine","genericName":"Cisplatin and Gemcitabine","slug":"cisplatin-and-gemcitabine","phase":"phase_2","mechanism":"Cisplatin is a platinum-based alkylating agent that cross-links DNA, thereby inhibiting DNA replication and transcription. Gemcitabine is a nucleoside analog that inhibits DNA synthesis by causing DNA strand breaks.","indications":["Non-small cell lung cancer","Ovarian cancer","Pancreatic cancer"],"catalyst":""},{"name":"Trifluridine-tipiracil plus Bevacizumab Alone","genericName":"Trifluridine-tipiracil plus Bevacizumab Alone","slug":"trifluridine-tipiracil-plus-bevacizumab-alone","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"regional chemotherapy","genericName":"regional chemotherapy","slug":"regional-chemotherapy","phase":"phase_3","mechanism":"Regional chemotherapy involves delivering high doses of chemotherapy directly to a specific area of the body, such as the liver, to treat cancer.","indications":["Liver cancer, including hepatocellular carcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for","headline":"Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Direc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPd3BSeFd1bzM0aWVROV9FNkVnQkR0b094X1M1bXp0LURJaGx5UVVTdGpzcWVTaUZuMEtzMzVldkJUcFl0UXJGdkptanJmTVZMc1UxOXVaaUtwdDlidjZWRzQtQlNjRWp6d2VXNVIwa1N5bk96cHFHRnpkaUp6cVV3S1hVOGlpSVR0Q1lZazRuLXpDT1JlQWY1WEtrWm92Mm12eXBQWnB5SllQSnpFVkM2NUdpUFdreHM?oc=5","date":"2026-04-02","type":"regulatory","source":"Stock Titan","summary":"Delcath (NASDAQ: DCTH) seeks approval to expand 2020 equity incentive plan - Stock Titan","headline":"Delcath (NASDAQ: DCTH) seeks approval to expand 2020 equity incentive plan","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcXFLYmRfUG0yeUxReDVvOXd0b2t1WUNZMUdQY3RtbTAxZDhSQWNEMWw2YjN3RDZDXzJ1X0l0bHFZRjZFbGVWcTg4QjI1VU9lMlA0OGxOTFhoZFV5bV90aGo1Z0dBMnFBd00xOU1ua2JJZVg1cE9YQm1qc2gwUGVrdHg4cEhpVDhmaURQeGpMN29NSGRaM29BOU81QkNfM19SZ1ZrZUdYRWZHSFpRNmhOM3VTdUM2RFMtRlprenJSdFU3SjdjNy02OGJ5QXh2TWpKcG9jVUF6N3ZyNG5oQlNGTm1R?oc=5","date":"2026-03-16","type":"pipeline","source":"MarketBeat","summary":"Divisadero Street Capital Management LP Invests $5.12 Million in Delcath Systems, Inc. $DCTH - MarketBeat","headline":"Divisadero Street Capital Management LP Invests $5.12 Million in Delcath Systems, Inc. $DCTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQSTVRemZBLTlvcUpnWGZ3ejZFSmgwNldXS3NGLWg3R2xucVZldm5hTDkxYkF5Ql9HX291S2czenREN3FCdGtVZ1M3eDEzTm84ODdER0treXhFY21teEgyZ2l5TUdSaTh6eDlGWV9HVVVqTC1Fb0FzYXFENmY1REhGNm9mNUE3ZTF1RmE1Wk9xRUx6QWtneU9udXRlRkRBWFpzdnhoSWo4emNFdWs0TGN5dFQyekJoZ21Yc1JJaFV6THlDMVB2LU03UVd5bmd6dHR0R0lJ?oc=5","date":"2025-10-20","type":"regulatory","source":"Benzinga","summary":"Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga","headline":"Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOT2pfX01hMm15NlVqX0pveDBweU9uUjlkM2pheWloS3Rxd1ZHdWpnZEM0QVQwZDVzRjRrT1U3ZGRTYW9KVEtGMHo3UG9HSFBBUktSV1RGRXZhV2xmejFZZWtnMTB2T1JHSTBweVFpZUtBaVlRWEdjYzhqQ1RsajExZTR3MEQ2YzM4RHB3VnlzWUpNOTFIZGs3SHpn?oc=5","date":"2024-05-28","type":"pipeline","source":"citybiz","summary":"Delcath Systems Appoints Bridget Martell, MA, MD to Board - citybiz","headline":"Delcath Systems Appoints Bridget Martell, MA, MD to Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNa0l4YUpGNVRpQVlqbG5oak1mb01QOXhYaDZJRmg0OXdCWE9LUUgtMDRLZm1ZV3ZuM2w1d0FVVFJZVWFZU0JfSVU0OFFEZTl0Z0dpLVo2NW5LR3V4OFMtZzZEWlktZUxNUG1RSHEwVUY1XzcwSl9VTGs4ckhIbF83NUNEWTVCSVk2Uk9kS0FkcEtoTTFqczRfQlI2VU9WbjgxYXhHajFBVDRycllNR0NyYWNHS29hX3pQM1FjLUNoRzRrc3RmaWloS0ln?oc=5","date":"2024-05-14","type":"earnings","source":"prnewswire.com","summary":"Delcath Systems Reports First Quarter 2024 Results and Business Highlights - prnewswire.com","headline":"Delcath Systems Reports First Quarter 2024 Results and Business Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQeDdqR1JLMHFTQl9RSWpKOVBnTG9mSi1fMV90NUVxQ1htNm5mbktqTkZWWjduYk1mNjEwOXFQd0hRTFVqeEhBeGNlV25qazd3Q0JES1hSbUdYaXBXYzJrX1BfWm1ySFFGOXVkblJ1QWlTNGtFVHdqM1dLOXlJV1ZlejhCUWFJaFlERjQ5YWloYXF1YVNhbEhQemJkWjhWMnlYRFRnWkdva2ctYW9ITk1xQUlzUXJ4VFUz?oc=5","date":"2023-08-16","type":"regulatory","source":"Pharmacy Times","summary":"FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma - Pharmacy Times","headline":"FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOUEJuYTcwcUlDaXh5R1JiNVM0S0FjdE9ydnBleWJSaTl5TU1yMUpuYnBQTnJ0Zmoyc0dUcEFlLXFNSEtYSk5lLXlFSzdad2QtUEVYcEZySXRlXzRhcnFSZlFZU0pQTHJPS0RZMzNWckZzYy1NMm1NMDkwUGxYTGV4bFFJWWNaZzhibVk1TWpkdDBuLW9zcEZ3dHVacGdsUExtX0p5Y215ZG52RVdNZGV1TU1CWW5mMDJNX0c2bDk1aEMteGw1S2NGUnpkZXVmcVg1dWhiUGpCQnBPN2RoUXVKSXVkZw?oc=5","date":"2022-02-22","type":"pipeline","source":"GlobeNewswire","summary":"Delcath Systems Announces Move to a Direct Sales & Marketing Model for CHEMOSAT® - GlobeNewswire","headline":"Delcath Systems Announces Move to a Direct Sales & Marketing Model for CHEMOSAT®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNcV9fZEdaa083eU9UWnRtaVViN2JmVmhua0tJalJLNEN4YnRWN2FKOGdyUHpfeHlfWVlLblMxMEc3OU5fa08xMk1aSXAwcFRKbEhmSzFMLXQzak9DWEJQY25YaWlndWtNaU85Wk81dGJDbllnYmYtaVZGbTdJQWF5RnZkdlhpd1lIZERYdHZtUHRlVld4ZmxfWDdxMzZkdEpBSmZkX9IBpAFBVV95cUxNcV9fZEdaa083eU9UWnRtaVViN2JmVmhua0tJalJLNEN4YnRWN2FKOGdyUHpfeHlfWVlLblMxMEc3OU5fa08xMk1aSXAwcFRKbEhmSzFMLXQzak9DWEJQY25YaWlndWtNaU85Wk81dGJDbllnYmYtaVZGbTdJQWF5RnZkdlhpd1lIZERYdHZtUHRlVld4ZmxfWDdxMzZkdEpBSmZkXw?oc=5","date":"2018-08-21","type":"trial","source":"RTTNews","summary":"ALRN On Watch, HJLI Hits New Low, COCP To Report HCV Data In Q4 - RTTNews","headline":"ALRN On Watch, HJLI Hits New Low, COCP To Report HCV Data In Q4","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9DVVRjNzNnLVJPTEs1VDEtbWp1cno4VV85LUVUem01QU1KZm9mQ3FIWXhrMkpTU2J6azZjXzk2RzFiMGR1eWRQcGVFVHNKcWJ3R1VFTVJRZl81YVdi?oc=5","date":"2017-07-19","type":"pipeline","source":"TradingView","summary":"DCTH Stock Price and Chart — NASDAQ:DCTH - TradingView","headline":"DCTH Stock Price and Chart — NASDAQ:DCTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE85eTlmWjVFZThZbWJkQndHQ2ZaWGV5RjlsZl9VQ3cyNXVCbkdBQjhvNmZBUGJYZlVvWDRlQ3pWSGNQcWtSb2dkRm9RbVpxRmxkMTc1REl4NFBJZjM2OFg0dG5hX3RPTUJ0WW1iM3d1MlJXV0h3VGs3aA?oc=5","date":"2017-03-28","type":"pipeline","source":"statnews.com","summary":"New cancer treatments should inform patients about quality of life beyond side effects - statnews.com","headline":"New cancer treatments should inform patients about quality of life beyond side effects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE12QnF0UXFwcktvc2JlOXRtaUFINS1QRHJkekJRRVBERUptZWZ2VHZDS3RyYWN0M1d2bUhSeXdubGxwdnRPWGU0Vm40SFpMaE9wN2N5WWNmOXZZOFFkRDB0R0loVnY?oc=5","date":"2009-08-24","type":"pipeline","source":"Inquirer.com","summary":"On the Boards - Inquirer.com","headline":"On the Boards","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}